SCHEMBL9199479

SCHEMBL9199479

NC(=N[N+](=O)[O-])C(N)CC[C@H](NC(=O)C(c1ccccc1)c1ccccc1)C(=O)NCc1cccc(O)c1

nearest known ligand 0.51

Predicted protein targets (top 7)

geneUniProtsupporting neighboursconfidence
▸ NPY1R P25929 18/20 0.51
▸ NPY5R Q15761 3/20 0.51
▸ NPFFR1 Q9GZQ6 2/20 0.51
▸ NPFFR2 Q9Y5X5 2/20 0.51
▸ NPY2R P49146 1/20 0.47
▸ NPY4R P50391 3/20 0.47
▸ MCHR1 Q99705 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9199470 1.00 NPY1R (0.51) NPY1RNPY5RNPFFR1NPFFR2NPY2R
SCHEMBL9203180 0.91 NPY1R (0.62) NPY1RNPY5RNPFFR1NPFFR2NPY4R
SCHEMBL9203188 0.91 NPY1R (0.62) NPY1RNPY5RNPFFR1NPFFR2NPY4R
SCHEMBL9196804 0.89 NPY1R (0.59) NPY1RNPY5RNPFFR1NPFFR2NPY4R
SCHEMBL9196815 0.89 NPY1R (0.59) NPY1RNPY5RNPFFR1NPFFR2NPY4R
SCHEMBL9198348 0.88 NPY1R (0.49) NPY1RNPY5RNPFFR1NPFFR2NPY2R
SCHEMBL9198360 0.88 NPY1R (0.49) NPY1RNPY5RNPFFR1NPFFR2NPY2R
SCHEMBL9195749 0.86 NPY1R (0.47) NPY1RNPY5RNPFFR1NPFFR2NPY4R
SCHEMBL9201322 0.86 NPY1R (0.47) NPY1RNPY5RNPFFR1NPFFR2NPY4R
SCHEMBL9201332 0.86 NPY1R (0.47) NPY1RNPY5RNPFFR1NPFFR2NPY4R

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0680469-A1 AMINOACID DERIVATES, MEDICAMENTS CONTAINING THESE COMPOUNDS AND PROCESS FOR PREPARING THE SAME Dr. Karl Thomae GmbH (DE) 1995-11-08 — — EP disclosed
WO-1994017035-A1 AMINOACID DERIVATES, MEDICAMENTS CONTAINING THESE COMPOUNDS AND PROCESS FOR PREPARING THE SAME DR. KARL THOMAE GMBH (DE) 1994-08-04 — — WO disclosed
Send feedback